GCM
Gladius Capital Management Portfolio holdings
AUM
$63.8M
1-Year Return
3.49%
This Quarter Return
-0.5%
1 Year Return
+3.49%
3 Year Return
+10.82%
5 Year Return
+16.08%
10 Year Return
+49.7%
AUM
$348M
AUM Growth
+$149M
(+74%)
Cap. Flow
+$150M
Cap. Flow
% of AUM
43.09%
Top 10 Holdings %
Top 10 Hldgs %
61.45%
Holding
378
New
86
Increased
126
Reduced
73
Closed
71
Top Buys
| 1 |
Microsoft
MSFT
|
$45M |
| 2 |
Apple
AAPL
|
$28.7M |
| 3 |
NVIDIA
NVDA
|
$26.6M |
| 4 |
Amazon
AMZN
|
$22.8M |
| 5 |
Advanced Micro Devices
AMD
|
$17.4M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$111M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$9.74M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$5.86M |
| 4 |
Invesco QQQ Trust
QQQ
|
$3.22M |
| 5 |
Walt Disney
DIS
|
$1.17M |
Sector Composition
| 1 | Technology | 40.17% |
| 2 | Consumer Discretionary | 14.23% |
| 3 | Financials | 8.88% |
| 4 | Consumer Staples | 8.28% |
| 5 | Industrials | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Viatris
VTRS
$12.2B
| $27.6K | ﹤0.01% |
2,800
-759
| -21% | -$7.48K |
|
|
AAN
227
DELISTED
The Aaron's Company, Inc.
AAN
| $27.3K | ﹤0.01% |
2,603
+1,157
| +80% | +$12.1K |
|
|
BCOV
228
DELISTED
Brightcove, Inc.
BCOV
| $26.8K | ﹤0.01% |
8,147
+464
| +6% | +$1.53K |
|
229
AnaptysBio
ANAB
$613M
| $26.6K | ﹤0.01% |
1,481
+399
| +37% | +$7.17K |
|
230
Mettler-Toledo International
MTD
$26.9B
| $26.6K | ﹤0.01% |
+24
| New | +$26.6K |
|
231
Supernus Pharmaceuticals
SUPN
$2.58B
| $26.3K | ﹤0.01% |
955
+240
| +34% | +$6.62K |
|
232
Radiant Logistics
RLGT
$305M
| $26.3K | ﹤0.01% |
4,656
-9,437
| -67% | -$53.3K |
|
233
Bio-Rad Laboratories Class A
BIO
$8B
| $26.2K | ﹤0.01% |
73
+18
| +33% | +$6.45K |
|
234
Phibro Animal Health
PAHC
$1.6B
| $26.1K | ﹤0.01% |
2,042
+47
| +2% | +$600 |
|
235
Perrigo
PRGO
$3.12B
| $25.8K | ﹤0.01% |
807
-21
| -3% | -$671 |
|
236
Atea Pharmaceuticals
AVIR
$267M
| $25.7K | ﹤0.01% |
8,581
+4,251
| +98% | +$12.8K |
|
237
Revvity
RVTY
$10.1B
| $25.7K | ﹤0.01% |
232
+106
| +84% | +$11.7K |
|
238
International Money Express
IMXI
$430M
| $25.1K | ﹤0.01% |
1,484
+229
| +18% | +$3.88K |
|
239
Zymeworks
ZYME
$1.14B
| $25K | ﹤0.01% |
3,940
+1,053
| +36% | +$6.68K |
|
240
Voyager Therapeutics
VYGR
$235M
| $24.7K | ﹤0.01% |
+3,182
| New | +$24.7K |
|
241
Orthofix Medical
OFIX
$575M
| $23.5K | ﹤0.01% |
1,831
+568
| +45% | +$7.31K |
|
|
ITOS
242
DELISTED
iTeos Therapeutics
ITOS
| $23.1K | ﹤0.01% |
2,105
+813
| +63% | +$8.9K |
|
243
Organon & Co
OGN
$2.7B
| $22.9K | ﹤0.01% |
1,318
-55
| -4% | -$955 |
|
|
EGRX
244
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $22.4K | ﹤0.01% |
1,421
+107
| +8% | +$1.69K |
|
245
Vanda Pharmaceuticals
VNDA
$272M
| $21.9K | ﹤0.01% |
5,074
+114
| +2% | +$492 |
|
246
Nuvation Bio
NUVB
$1.33B
| $21.6K | ﹤0.01% |
16,082
+3,198
| +25% | +$4.29K |
|
247
Vor Biopharma
VOR
$248M
| $21.2K | ﹤0.01% |
+10,009
| New | +$21.2K |
|
|
DZSI
248
DELISTED
DZS Inc. Common Stock
DZSI
| $19.9K | ﹤0.01% |
9,497
+2,827
| +42% | +$5.94K |
|
249
Vir Biotechnology
VIR
$732M
| $19.8K | ﹤0.01% |
+2,111
| New | +$19.8K |
|
250
Century Therapeutics
IPSC
$43.6M
| $19.6K | ﹤0.01% |
9,810
+3,564
| +57% | +$7.13K |
|